PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
Leap Investments LP | 69,496 | $150,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |